US Stock MarketDetailed Quotes

INMB INmune Bio

Watchlist
  • 4.880
  • +0.080+1.67%
Close Nov 26 16:00 ET
  • 4.880
  • 0.0000.00%
Post 20:02 ET
108.57MMarket Cap-2238P/E (TTM)

INmune Bio Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
-63.16%14K
-58.56%155K
-71.13%28K
-56.12%43K
187.50%46K
-76.69%38K
106.63%374K
-40.49%97K
Operating revenue
--0
--0
-63.16%14K
-58.56%155K
-71.13%28K
-56.12%43K
187.50%46K
-76.69%38K
106.63%374K
-40.49%97K
Cost of revenue
Gross profit
Operating expense
43.34%12.29M
52.78%9.87M
70.73%11.03M
13.57%29.9M
46.49%8.41M
13.66%8.57M
0.83%6.46M
-2.71%6.46M
-10.26%26.33M
-37.57%5.74M
Selling and administrative expenses
-14.19%2.22M
21.78%2.81M
0.43%2.34M
3.94%9.62M
3.05%2.4M
8.56%2.59M
4.24%2.31M
-0.17%2.33M
5.31%9.26M
9.60%2.33M
-General and administrative expense
-14.19%2.22M
21.78%2.81M
0.43%2.34M
3.94%9.62M
3.05%2.4M
8.56%2.59M
4.24%2.31M
-0.17%2.33M
5.31%9.26M
9.60%2.33M
Research and development costs
68.20%10.07M
70.03%7.05M
110.33%8.69M
18.78%20.27M
76.16%6.01M
16.01%5.99M
-0.98%4.15M
-4.08%4.13M
-16.92%17.07M
-51.75%3.41M
Operating profit
-44.07%-12.29M
-53.88%-9.87M
-71.52%-11.02M
-14.60%-29.74M
-48.51%-8.38M
-14.58%-8.53M
-0.36%-6.41M
0.85%-6.42M
10.98%-25.95M
37.52%-5.64M
Net non-operating interest income expense
Other net income (expense)
651.43%193K
232.22%119K
92.92%-8K
80.19%-267K
84.82%-29K
87.59%-35K
80.00%-90K
73.41%-113K
-13.56%-1.35M
70.20%-191K
Other non- operating income (expenses)
651.43%193K
232.22%119K
92.92%-8K
80.19%-267K
84.82%-29K
87.59%-35K
80.00%-90K
73.41%-113K
-13.56%-1.35M
70.20%-191K
Income before tax
-41.22%-12.09M
-49.92%-9.75M
-68.68%-11.03M
-9.92%-30.01M
-44.15%-8.41M
-10.85%-8.56M
4.93%-6.5M
5.32%-6.54M
10.02%-27.3M
39.69%-5.83M
Income tax
Net income
-41.22%-12.09M
-49.92%-9.75M
-68.68%-11.03M
-9.92%-30.01M
-44.15%-8.41M
-10.85%-8.56M
4.93%-6.5M
5.32%-6.54M
10.02%-27.3M
39.69%-5.83M
Net income continuous Operations
-41.22%-12.09M
-49.92%-9.75M
-68.68%-11.03M
-9.92%-30.01M
-44.15%-8.41M
-10.85%-8.56M
4.93%-6.5M
5.32%-6.54M
10.02%-27.3M
39.69%-5.83M
Minority interest income
Net income attributable to the parent company
-41.22%-12.09M
-49.92%-9.75M
-68.68%-11.03M
-9.92%-30.01M
-44.15%-8.41M
-10.85%-8.56M
4.93%-6.5M
5.32%-6.54M
10.02%-27.3M
39.69%-5.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-41.22%-12.09M
-49.92%-9.75M
-68.68%-11.03M
-9.92%-30.01M
-44.15%-8.41M
-10.85%-8.56M
4.93%-6.5M
5.32%-6.54M
10.02%-27.3M
39.69%-5.83M
Basic earnings per share
-25.00%-0.6
-38.89%-0.5
-69.44%-0.61
-9.87%-1.67
-46.88%-0.47
-11.63%-0.48
5.26%-0.36
7.69%-0.36
19.15%-1.52
41.82%-0.32
Diluted earnings per share
-25.00%-0.6
-38.89%-0.5
-69.44%-0.61
-9.87%-1.67
-46.88%-0.47
-11.63%-0.48
5.26%-0.36
7.69%-0.36
19.15%-1.52
41.82%-0.32
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 00-63.16%14K-58.56%155K-71.13%28K-56.12%43K187.50%46K-76.69%38K106.63%374K-40.49%97K
Operating revenue --0--0-63.16%14K-58.56%155K-71.13%28K-56.12%43K187.50%46K-76.69%38K106.63%374K-40.49%97K
Cost of revenue
Gross profit
Operating expense 43.34%12.29M52.78%9.87M70.73%11.03M13.57%29.9M46.49%8.41M13.66%8.57M0.83%6.46M-2.71%6.46M-10.26%26.33M-37.57%5.74M
Selling and administrative expenses -14.19%2.22M21.78%2.81M0.43%2.34M3.94%9.62M3.05%2.4M8.56%2.59M4.24%2.31M-0.17%2.33M5.31%9.26M9.60%2.33M
-General and administrative expense -14.19%2.22M21.78%2.81M0.43%2.34M3.94%9.62M3.05%2.4M8.56%2.59M4.24%2.31M-0.17%2.33M5.31%9.26M9.60%2.33M
Research and development costs 68.20%10.07M70.03%7.05M110.33%8.69M18.78%20.27M76.16%6.01M16.01%5.99M-0.98%4.15M-4.08%4.13M-16.92%17.07M-51.75%3.41M
Operating profit -44.07%-12.29M-53.88%-9.87M-71.52%-11.02M-14.60%-29.74M-48.51%-8.38M-14.58%-8.53M-0.36%-6.41M0.85%-6.42M10.98%-25.95M37.52%-5.64M
Net non-operating interest income expense
Other net income (expense) 651.43%193K232.22%119K92.92%-8K80.19%-267K84.82%-29K87.59%-35K80.00%-90K73.41%-113K-13.56%-1.35M70.20%-191K
Other non- operating income (expenses) 651.43%193K232.22%119K92.92%-8K80.19%-267K84.82%-29K87.59%-35K80.00%-90K73.41%-113K-13.56%-1.35M70.20%-191K
Income before tax -41.22%-12.09M-49.92%-9.75M-68.68%-11.03M-9.92%-30.01M-44.15%-8.41M-10.85%-8.56M4.93%-6.5M5.32%-6.54M10.02%-27.3M39.69%-5.83M
Income tax
Net income -41.22%-12.09M-49.92%-9.75M-68.68%-11.03M-9.92%-30.01M-44.15%-8.41M-10.85%-8.56M4.93%-6.5M5.32%-6.54M10.02%-27.3M39.69%-5.83M
Net income continuous Operations -41.22%-12.09M-49.92%-9.75M-68.68%-11.03M-9.92%-30.01M-44.15%-8.41M-10.85%-8.56M4.93%-6.5M5.32%-6.54M10.02%-27.3M39.69%-5.83M
Minority interest income
Net income attributable to the parent company -41.22%-12.09M-49.92%-9.75M-68.68%-11.03M-9.92%-30.01M-44.15%-8.41M-10.85%-8.56M4.93%-6.5M5.32%-6.54M10.02%-27.3M39.69%-5.83M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -41.22%-12.09M-49.92%-9.75M-68.68%-11.03M-9.92%-30.01M-44.15%-8.41M-10.85%-8.56M4.93%-6.5M5.32%-6.54M10.02%-27.3M39.69%-5.83M
Basic earnings per share -25.00%-0.6-38.89%-0.5-69.44%-0.61-9.87%-1.67-46.88%-0.47-11.63%-0.485.26%-0.367.69%-0.3619.15%-1.5241.82%-0.32
Diluted earnings per share -25.00%-0.6-38.89%-0.5-69.44%-0.61-9.87%-1.67-46.88%-0.47-11.63%-0.485.26%-0.367.69%-0.3619.15%-1.5241.82%-0.32
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data